For example, many studies reported that inhibiting the GPR30 receptor on the cell surface of CAFs can inhibit the level of CXCL12 secreted by CAFs, reduce the recruitment of macrophages and M2-type polarization, thereby impairing the ability of prostate cancer cells to metastasize and invade [73]. The gene discussed is CXCL12; the disease is prostate carcinoma.